Time:
0900 - 1030 PST
1330 - 1700 EDT
1730-2100 UTC
Zoom Meeting Details
Attendees
Chair:
AG Members:
Invitees:
Observers
Apologies:
Meeting Files:
Meeting minutes:
The call recording is located here.
Objectives
- Obtain consensus on agenda items
Discussion items
Item | Description | Owner | Notes | Action |
---|---|---|---|---|
1 | Call to order and role call | This meeting is being recorded to ensure that important discussion points are not missed in the minutes. The recording will be available to the SNOMED International community. Joining the meeting by accepting the Zoom prompt declares that you have no objection to your comments being recorded |
| |
2 | Conflicts of interest and agenda review | |||
3 | Modeling of "No known X" | Inconsistent representation of "No known...(situation)" with proposed remodeling. See attached document. Different resolution depending on whether the Situation is a "Finding with explicit context" (allowed range = << 410514004 |Finding context value (qualifier value)|) or a "Procedure with explicit context" (allowed range - << 288532009 |Context values for actions (qualifier value)|)? Discussion: Proposed definition for "No known" after consultation with EAG members. Differs from "unknown" in that it implies a reasonable effort to acquire the information, or a lack of evidence to support the issue at hand as opposed to a general lack of information for any reason. Agreed in the last meeting in Atlanta that it should be a sibling of "Unknown". Def: Decision: | ||
MRCM change and revision of Physical object hierarchy |
Discussion: Decision: | |||
Updating of Neuroendocrine tumors. Part of Histology update project | Briefing note describing the initial phase of the project to update the Neoplasm (morphologic abnormality) hierarchy to conform to the latest WHO Blue book. Discussion: Decision: | |||
Inactivation of "Role groupers" from substances and products | Discussion on the briefing note to inactivate role groupers from Substance and Medicinal product (attached) Discussion: Decision: | |||
AOB | EAG | |||
Next meeting | EAG | Meetings will continue on the fourth Monday of the month and may be cancelled if necessary. | ||